FDA Drug recall D-0664-2022
Ketamine 50 mg Infusion (LV 1) Solution in 250 mL bags, Rx only, Family Pharmacy of Statesville, Inc
- FDA Drug
- Class II
- terminated
- Published 2022-03-23
On 2022-03-23 the FDA classified a Class II recall of Ketamine 50 mg Infusion (LV 1) Solution in 250 mL bags, Rx only, Family Pharmacy of Statesville, Inc by Family Pharmacy, citing lack of Assurance of Sterility.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0664-2022 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2020-08-06 |
| Published | 2022-03-23 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Family Pharmacy |
| Distribution | NC |
Product
Ketamine 50 mg Infusion (LV 1) Solution in 250 mL bags, Rx only, Family Pharmacy of Statesville, Inc.
Reason
Lack of Assurance of Sterility
Identifiers
| code_info | Lot #: 07212020@1 BUD: 8/4/2020; 07232020@2 BUD: 8/6/2020; 07302020@2 BUD: 8/13/2020 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0664-2022%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.